Professor of Medicine, University of Chicago Medicine
Endocrinology
Dr. Murray J. Favus, MD
Murray J. Favus, MD is an expert in the field of Endocrinology. He graduated from University of Illinois College of Medicine. He received awards:"Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Murray J. Favus is a published MD. He has 101 papers published. The most current publication "Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats." Murray Favus accepts Medicare payments and is listed with Medicare.gov.
Publications
- TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
- The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.
- Increased biological response to 1,25(OH)2D3 in genetic hypercalciuric stone-forming rats.
- Bone health issues in sarcoidosis.
- The risk of kidney stone formation: the form of calcium matters.
- Bisphosphonates for osteoporosis.
- Ethanol extract of Fructus Ligustri Lucidi increases circulating 1,25-dihydroxyvitamin D3 by inducing renal 25-hydroxyvitamin D-1α hydroxylase activity.
- Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail.
- Following BMD in patients on bisphosphonates: another perspective.
- Ovariectomy worsens secondary hyperparathyroidism in mature rats during low-Ca diet.
- Diabetes and the risk of osteonecrosis of the jaw.
- Postmenopausal osteoporosis and the detection of so-called secondary causes of low bone density.
- Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats.
- Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.
- Comparison of T-scores from different skeletal sites in differentiating postmenopausal women with and without prevalent vertebral fractures.
- Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
- Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria.
- Noninvasive assessment of bone structure.
- Evidence for absorption of ionic calcium and soluble calcium complexes by the duodenum and cecum in the rat.
- Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey.
- Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
- Insulin-like growth factor-I stimulates renal 1, 25-dihydroxycholecalciferol synthesis in old rats fed a low calcium diet.
- The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome.
- Weekly administration of alendronate: rationale and plan for clinical assessment.
- Computerized analysis of radiographic bone patterns: effect of imaging conditions on performance.
- Normalized BMD as a predictor of bone strength.
- Computerized radiographic texture measures for characterizing bone strength: a simulated clinical setup using femoral neck specimens.
- Characterization of bone quality using computer-extracted radiographic features.
- Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
- Bone mineral density assessment in children with inflammatory bowel disease.
- Insulin-like growth factor I increases renal 1,25(OH)2D3 biosynthesis during low-P diet in adult rats.
- Diet and calcium: the end of an era?
- Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
- Response of genetic hypercalciuric rats to a low calcium diet.
- Computerized radiographic analysis of osteoporosis: preliminary evaluation.
- Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption.
- Structure-function requirements of parathyroid hormone for stimulation of 1,25-dihydroxyvitamin D3 production by rat renal proximal tubules.
- Loss of parathyroid hormone-stimulated 1,25-dihydroxyvitamin D3 production in aging does not involve protein kinase A or C pathways.
- Multifractal radiographic analysis of osteoporosis.
- Hypercalciuria: lessons from studies of genetic hypercalciuric rats.
- Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat.
- Characterization of carrier females and affected males with X-linked recessive nephrolithiasis.
- Diagnosis and treatment of calcium kidney stones.
- Structure-function relationship of human parathyroid hormone in the regulation of vitamin D receptor expression in osteoblast-like cells (ROS 17/2.8).
- Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Stud...
- Continuing occurrence of thyroid nodules after head and neck irradiation. Relation to plasma thyroglobulin concentration.
- Hyperparathyroidism in nephrolithiasis.
- Primary hyperparathyroidism and basal cell nevus syndrome.
- Nodules in irradiated thyroids.
- Effects of diet calcium and 1,25-dihydroxyvitamin D3 on colon calcium active transport.
- Does mild, asymptomatic hyperparathyroidism require surgery?
- Scintigraphic thyroid abnormalities after radiation. A controlled study with 99mTc pertechnetate scanning.
- [Vitamin D physiology and its application to disorders of calcium metabolism].
- Factors affecting calcium metabolism in disorders of the kidney.
- Treatment of renal calculi.
- Hepatic vitamin D 25-hydroxylase: inhibition by bile duct ligation or bile salts.
- The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
- Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
- Idiopathic hypercalciuria in calcium nephrolithiasis.
- Effects of chlorothiazide administration and dietary calcium restriction on parathyroid function, vitamin D metabolism and intestinal calcium absorption in the rat.
- Effects of chlorothiazide on 1,25-dihydroxyvitamin D3, parathyroid hormone, and intestinal calcium absorption in the rat.
- Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
- Kinetic characteristics of calcium absorption and secretion by rat colon.
- Idiopathic hypercalciuria.
- Effects of trifluoperazine, ouabain, and ethacrynic acid on intestinal calcium transport.
- Secondary hyperparathyroidism in children with symptomatic idiopathic hypercalciuria.
- Mechanism of chronic hypocalciuria with chlorthalidone: reduced calcium absorption.
- Effects of 1,25-dihydroxyvitamin D3 on colonic calcium transport in vitamin D-deficient and normal rats.
- Elevated 1,25(OH)2D3, intestinal absorption, and renal mineral conservation in male rats.
- Evidence for size and charge permselectivity of rat ascending colon. Effects of ricinoleate and bile salts on oxalic acid and neutral sugar transport.
- Effects of lactose on calcium absorption and secretion by rat ileum.
- Effects of metabolic acidosis on PTH and 1,25(OH)2D3 response to low calcium diet.
- Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subj...
- Case report: clinical pathological correlations in a case of primary parathyroid carcinoma.
- Effects of somatostatin on intestinal calcium transport in the rat.
- Effects of calcium intake on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules.
- Treatment of vitamin D intoxication.
- Effects of dietary calcium restriction and chronic thyroparathyroidectomy on the metabolism of (3H)25-hydroxyvitamin D3 and the active transport of calcium by rat inte...
- Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats.
- Effects of cortisone administration on the metabolism and localization of 25-hydroxycholecalciferol in the rat.
- Effects of 25-hydroxyvitamin D3 on rat duodenum, jejunum, and ileum. Correlation of calcium active transport with tissue levels of vitamin D3 metabolites.
- Tests in cushing''s syndrome.
- Radiation-induced tumors of the head and neck following childhood irradiation. Prospective studies.
- Factors that influence absorption and secretion of calcium in the small intestine and colon.
- Vitamin D metabolism and osteomalacia in cystic fibrosis.
- Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat.
- Role of fetal 1,25-dihydroxyvitamin D production in intrauterine phosphorus and calcium homeostasis.
- Ca and P regulation of 1,25(OH)2D3 synthesis by vitamin D-replete rat tubules during acidosis.
- Mechanism of chronic hypercalciuria with furosemide: increased calcium absorption.
- Is estrogen preferable to surgery for postmenopausal women with primary hyperparathyroidism?
- Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria.
- Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport.
- Effects of medium pH on duodenal and ileal calcium active transport in the rat.
- Response of serum 1,25(OH)2D3 to variation of ionized calcium during chronic acidosis.
- Effects of dietary calcium restriction on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules.
- Effects of 1,25(OH)2D3 on enterocyte basolateral membrane Ca transport in rats.
- Effect of hypercalcemia-producing tumor on 1,25(OH)2D3 biosynthesis in athymic mice.
- Evidence for in vivo upregulation of the intestinal vitamin D receptor during dietary calcium restriction in the rat.
- Intestinal calcium absorption: have we absorbed enough from research to have a test for the patient?
- Effects of chronic metabolic alkalosis on Ca2+, PTH and 1,25(OH)2D3 in the rat.
Schools
University Of Illinois College Of Medicine Chicago
Cleveland Clinic
Beth Israel Hospital
Doctors Specialties
- Internal Medicine
- Endocrinology
Accepted Insurances
- Aetna
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Coventry Health Care
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- HealthLink PPO
- HealthPartners
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Principal Life
- Sagamore Plus
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Beth Israel Deaconess Medical Center -
Cleveland Clinic Foundation -
University of Illinois College of Medicine
Hospital
-
University of Chicago Medical Center
Drug Facts
| NPI NUMBER | 1962564427 | |
| NPPES Provider LastName | FAVUS | |
| NPPES Provider FirstName | MURRAY | |
| NPPES Provider ZIPCode | 605276686 | |
| NPPES Provider State | IL | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 279.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962564427 |
| Last Name Of The Provider | FAVUS |
| First Name Of The Provider | MURRAY |
| View All |
Similar Doctors
|
Dr. Marshall H. Chin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan Glick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesse K. Park, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elbert S. Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth S. Rich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nir Y. Uriel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard H. Bertenshaw Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nila Vora, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamara P. Vokes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann M. Lawrence, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Silvana Pannain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roy Weiss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Plamen D. Penev, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel Refetoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Uzma N. Syed, MD
This Doctor is OpenDoctor Recommended.
|